102,219 Shares in Bath & Body Works, Inc. $BBWI Bought by Cibc World Market Inc.

Cibc World Market Inc. bought a new position in shares of Bath & Body Works, Inc. (NYSE:BBWIFree Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm bought 102,219 shares of the company’s stock, valued at approximately $2,053,000.

Several other large investors have also bought and sold shares of the stock. Allianz Asset Management GmbH raised its position in shares of Bath & Body Works by 58.8% in the 3rd quarter. Allianz Asset Management GmbH now owns 263,628 shares of the company’s stock worth $6,791,000 after acquiring an additional 97,640 shares in the last quarter. SG Americas Securities LLC raised its position in shares of Bath & Body Works by 725.3% in the 4th quarter. SG Americas Securities LLC now owns 466,338 shares of the company’s stock worth $9,364,000 after acquiring an additional 409,831 shares in the last quarter. Chase Investment Counsel Corp bought a new position in shares of Bath & Body Works in the 4th quarter worth about $1,606,000. Jupiter Asset Management Ltd. raised its position in shares of Bath & Body Works by 553.2% in the 3rd quarter. Jupiter Asset Management Ltd. now owns 3,714,499 shares of the company’s stock worth $95,685,000 after acquiring an additional 3,145,797 shares in the last quarter. Finally, Wedge Capital Management L L P NC raised its position in shares of Bath & Body Works by 49.9% in the 4th quarter. Wedge Capital Management L L P NC now owns 214,362 shares of the company’s stock worth $4,304,000 after acquiring an additional 71,349 shares in the last quarter. 95.14% of the stock is owned by institutional investors.

Bath & Body Works Stock Performance

BBWI stock opened at $18.33 on Wednesday. The stock’s 50 day simple moving average is $18.62 and its 200 day simple moving average is $20.03. Bath & Body Works, Inc. has a fifty-two week low of $14.27 and a fifty-two week high of $33.96. The company has a market cap of $3.70 billion, a P/E ratio of 5.15, a price-to-earnings-growth ratio of 1.82 and a beta of 1.42.

Bath & Body Works (NYSE:BBWIGet Free Report) last posted its quarterly earnings results on Wednesday, May 27th. The company reported $0.32 earnings per share for the quarter, topping analysts’ consensus estimates of $0.29 by $0.03. Bath & Body Works had a negative return on equity of 45.34% and a net margin of 10.03%.The business had revenue of $1.38 billion for the quarter, compared to the consensus estimate of $1.36 billion. During the same period in the prior year, the business earned $0.49 EPS. The firm’s revenue for the quarter was down 3.2% on a year-over-year basis. Bath & Body Works has set its Q2 2026 guidance at 0.300-0.300 EPS and its FY 2026 guidance at 2.400-2.650 EPS. Equities analysts predict that Bath & Body Works, Inc. will post 2.62 earnings per share for the current year.

Bath & Body Works Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, June 19th. Investors of record on Friday, June 5th will be paid a dividend of $0.20 per share. This represents a $0.80 dividend on an annualized basis and a yield of 4.4%. The ex-dividend date of this dividend is Friday, June 5th. Bath & Body Works’s dividend payout ratio is 22.47%.

Analysts Set New Price Targets

BBWI has been the topic of a number of research analyst reports. TD Cowen increased their price target on Bath & Body Works from $20.00 to $25.00 and gave the stock a “buy” rating in a report on Thursday, May 28th. Barclays cut their price target on Bath & Body Works from $25.00 to $23.00 and set an “equal weight” rating on the stock in a report on Thursday, May 28th. The Goldman Sachs Group cut their price target on Bath & Body Works from $26.00 to $23.00 and set a “neutral” rating on the stock in a report on Thursday, May 28th. Wells Fargo & Company cut their price target on Bath & Body Works from $29.00 to $25.00 and set an “overweight” rating on the stock in a report on Thursday, May 28th. Finally, Deutsche Bank Aktiengesellschaft increased their price target on Bath & Body Works from $21.00 to $22.00 and gave the stock a “hold” rating in a report on Tuesday, March 3rd. Three analysts have rated the stock with a Buy rating, fourteen have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, Bath & Body Works currently has an average rating of “Hold” and an average price target of $21.93.

Get Our Latest Stock Report on Bath & Body Works

About Bath & Body Works

(Free Report)

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.

See Also

Want to see what other hedge funds are holding BBWI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bath & Body Works, Inc. (NYSE:BBWIFree Report).

Institutional Ownership by Quarter for Bath & Body Works (NYSE:BBWI)

Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.